Published in Patient Care Law Weekly, July 16th, 2006
Nochur has extensive industry experience in the areas of regulatory affairs and overall drug development. At Alnylam, she will be responsible for leading the global regulatory strategy for the company's development-stage programs and overseeing regulatory operations, and will be a member of the management team.
"Sara is an outstanding addition to the Alnylam team," said John Maraganore, PhD, president and CEO of Alnylam Pharmaceuticals. "Her extensive product development and regulatory experience will be an...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Patient Care Law Weekly